Saturday, January 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – January 14, 2018

by Global Biodefense Staff
January 14, 2018
Health Security Headlines from Global Biodefense

Health Security Headlines from Global BiodefenseSee what we’re reading this week at Global Biodefense on topics including flu pandemic readiness shortfalls, CDP resumes live-agent training, and an Ebola pinprick test starts field trials.

POLICY, PRACTICES & POLITICS

  • Experts decry lack of flu pandemic readiness, commitment (CIDRAP)
  • We are not ready for the influenza pandemic (Seattle Times)
  • Global respiratory surveillance program detects dangerous pathogens (Stripes)
  • The truth about those 7 words ‘banned’ at the CDC (CNN)
  • Ban on deadly pathogen research lifts, but controversy remains (Harvard)
  • Who will answer the call in the next outbreak? (STAT)
  • Fallout from ‘nuclear button’ tweets: jump in sales of radiation drug (NPR)

SELECT AGENTS

  • Inside the hot zone: A discussion of Ebola virus and BSL4 containment (ASM)
  • Yersinia pestis survival and replication in potential ameba reservoir (EID)
  • Center for Domestic Preparedness to resume live-agent training (EMS World)
  • The resumption of live-agent training at the CDP (Anniston Star)
  • Thermostable ricin toxin vaccine development (Soligenix)
  • Pinprick test designed for Ebola heads for field trial (SciDevNet)
  • Wound botulism in an intravenous drug user (Crimson)

OUTBREAK NEWS & THREAT SURVEILLANCE

  • Japan starts culling chicken after confirming bird flu outbreak (Reuters)
  • Dengue virus exposures among deployed U.S. military personnel (PubMed)
  • Flu in U.S. now widespread but season may be peaking (Reuters)

RESEARCH & TECH

  • Resistance to common germs poses a hurdle to new gene therapies (SciAm)
  • CRISPR hits a snag: Our immune systems may attack the treatment (STAT)
  • Rapid differentiation of Acinetobacter baumannii strains by Raman (NCBI)
  • Continental synchronicity of human influenza virus epidemics (PLOS)
  • The bright side of synthetic biology and CRISPR (Pandora Report)
  • Human antibodies made in cows could be developed to treat MERS (Reuters)
  • Mortality from pandemic A/H1N1 2009 influenza in England (BMJ)

SPECIAL INTEREST

  • Infectious disease mapping challenge launched (Pandora Report)
  • Public health measures on the 1918 influenza pandemic in U.S. cities (PLOS)
  • Busting 10 common myths about the “greatest pandemic in history” (SciAm)
  • Ten myths about the 1918 flu pandemic (Smithsonian)
  • Is Captain America a biological weapon? (Bifurcated Needle)
  • A brief history of shigella (NCBI)

Related Posts

Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Biodefense Headlines – 15 December 2022
News Scan

Biodefense Headlines – 15 December 2022

December 15, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC